Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10636 (
tau protein
)
5,110
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The regulation of gene expression in response to environmental signals and metabolic imbalances is a key step in maintaining cellular homeostasis.
BTB and CNC homology 1
(
BACH1
) is a heme-binding transcription factor repressing the transcription from a subset of MAF recognition elements at low intracellular heme levels. Upon heme binding,
BACH1
is released from the MAF recognition elements, resulting in increased expression of antioxidant response genes. To systematically address the gene regulatory networks involving
BACH1
, we combined chromatin immunoprecipitation sequencing analysis of
BACH1
target genes in HEK 293 cells with knockdown of
BACH1
using three independent types of small interfering RNAs followed by transcriptome profiling using microarrays. The 59
BACH1
target genes identified by chromatin immunoprecipitation sequencing were found highly enriched in genes showing expression changes after
BACH1
knockdown, demonstrating the impact of
BACH1
repression on transcription. In addition to known and new
BACH1
targets involved in heme degradation (HMOX1, FTL, FTH1, ME1, and SLC48A1) and redox regulation (GCLC, GCLM, and SLC7A11), we also discovered
BACH1
target genes affecting cell cycle and apoptosis pathways (ITPR2, CALM1, SQSTM1, TFE3, EWSR1, CDK6, BCL2L11, and MAFG) as well as subcellular transport processes (CLSTN1, PSAP,
MAPT
, and vault RNA). The newly identified impact of
BACH1
on genes involved in neurodegenerative processes and proliferation provides an interesting basis for future dissection of
BACH1
-mediated gene repression in neurodegeneration and virus-induced cancerogenesis.
...
PMID:The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. 2155 18